Ivermectin Key for Early COVID-19 Treatment: Dr. Paul Marik

Dr. Paul Marik, co-founder of the Front Line COVID-19 Critical Care Alliance (FLCCC) and former Chief of the Division of Pulmonary and Critical Care Medicine at Eastern Virginia Medical School, at the FLCCC conference "Understanding & Treating Spike Protein-Induced Diseases" in Kissimmee, Fla. on Oct. 14, 2022. The Epoch Times

Ivermectin is a key drug for early COVID-19 treatment, Dr. Paul Marik says.

Ivermectin, an anti-parasitic drug, has shown efficacy against COVID-19 in some studies as a prophylactic and treatment.